Epocrates Appoints Erick Tseng to Board of Directors

SAN MATEO, Calif., Aug. 30, 2011 (GLOBE NEWSWIRE) -- Epocrates, Inc. (Nasdaq:EPOC - News), a leading provider of mobile drug reference tools to healthcare professionals and interactive services to the healthcare industry, today announced the appointment of Facebook head of mobile products Erick Tseng to its board of directors effective immediately.

"Erick is a dynamic leader who will add a new dimension to our board," said Rose Crane, president and chief executive officer of Epocrates. "We are delighted to welcome him and look forward to tapping his proven track record of mobile innovation and expertise in user engagement."

Prior to Facebook, Tseng was lead product manager at Google where he was responsible for the development and launch of Android, Google's open-source mobile operating system. Before joining Google, Tseng was an associate at McKinsey & Company. He has also held various engineering and product management positions at Microsoft and Yahoo.

"Epocrates is right at the intersection of mobile and health -- two of my personal passions," said Tseng. "As the nation moves toward digital, patient-centric health care, Epocrates is in an ideal position to help enrich the physician and patient experience with a greater degree of engagement and connectivity."

About Epocrates, Inc.

Epocrates, Inc. (Nasdaq:EPOC - News), developers of the #1 most used mobile medical app among U.S. physicians, creates point-of-care digital solutions that enhance the practice of medicine. More than 1.3 million healthcare professionals, including 50 percent of U.S. physicians, use Epocrates' solutions to help improve patient care and practice efficiencies with its drug reference, educational and clinical apps. The new Epocrates mobile and web-based EHR solution, designed for solo and small practice physicians, is affordable, easy-to-use and further supports physician workflow and patient outcomes. The company also partners with the healthcare industry, including top pharmaceutical companies, to engage with its clinician network through effective, interactive services. For more information about Epocrates, please visit www.epocrates.com/company.

Epocrates is a trademark of Epocrates, Inc., in the U.S. and other countries. All other trademarks and trade names referred to in this press release are the property of their respective owners.

 

Contact:

INVESTORS:
Julie Tracy
Sr. Vice President, Chief Communications Officer
(609) 583-1464
[email protected]
MEDIA:
Erica Sniad Morgenstern
Director, Public Relations and Communication
(650) 227-6907
[email protected]

Suggested Articles

Nearly 10,000 patients involved in research studies were impacted by a third-party privacy breach that may have exposed their medical diagnoses, test results…

Veterans Health Administration medical facilities currently have a paper medical record backlog that if stacked up would be 5.15 miles high, according to the…

The Department of Health and Human Services announced proposed changes to privacy restrictions on patients' substance use treatment records.